missing translation for 'onlineSavingsMsg'
Learn More

PEPperCHIP™ Oncovirus Epitope Microarray

Product Code. 16307778
Quantity: 1 Slide
Click to view available options
:
Quantity: 1 Slide
This item is not returnable. View return policy
This item is not returnable. View return policy

Oncovirus Epitope Microarray with 4463 epitope specific peptides printed in duplicate. The microarray can be used for epitope mapping, serum screening or biomarker discovery.

  • Microarray Content: 3653 linear B-cell epitopes of human oncoviruses from the Immune Epitope Database including 7 citrullinated peptides and the corresponding arginine variants
  • Database Epitope Lengths: 3 to 50 aa
  • Peptide Lengths: 3 aa to 20 aa depending on the epitope length; longer epitopes were translated into overlapping 20 aa peptides
  • Number of Peptides: 4463 printed in duplicate and HA, polio and c-Myc control peptides

Specifications

Coating PEGMA/PMMA
Description 1 array copy per microarray
Quantity 1 Slide
Method of Attachment Combinatorial peptide synthesis by amino acid laser printing
Thickness (Metric) 1 mm
Certifications/Compliance ISO 9001:2015
Color Transparent
Regulatory Status RUO
Barcode Individual barcode for each microarray
Material Microscopic Glass
Type High-density Peptide Microarray
For Use With (Application) Antibody validation, epitope mapping, serum screening, biomarker discovery
Sterility Non-sterile
Dimensions (LxW) 75.4 x 25 mm
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
PEPperCHIP™ Oncovirus Epitope Microarray >

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.